Skip to Main Content

Author Details

Chip Stewart
Broad Institute of MIT and Harvard
2004
70
48
PMIDPaper TitleJournal TitlePublished Year
36477267MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.Cancer Discov2023
38019104Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.Cancer Res Commun2023
37794034Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.Nat Commun2023
37024582Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.Nat Genet2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36624313Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.Nat Med2023
36477267MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.Cancer Discov2023
38019104Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.Cancer Res Commun2023
37794034Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.Nat Commun2023
37024582Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.Nat Genet2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36624313Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.Nat Med2023
35243413Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.Cell Rep Med2022
35705541Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Nat Commun2022
36215125Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer.Clin Cancer Res2022
35927489Molecular map of chronic lymphocytic leukemia and its impact on outcome.Nat Genet2022
35190823Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.Clin Cancer Res2022
35243413Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.Cell Rep Med2022
35705541Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Nat Commun2022
36215125Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer.Clin Cancer Res2022
35927489Molecular map of chronic lymphocytic leukemia and its impact on outcome.Nat Genet2022
35190823Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.Clin Cancer Res2022
34568833<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.Blood Cancer Discov2021
33888599Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.Science2021
33888597Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident.Science2021
34568833<i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.Blood Cancer Discov2021
33888599Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.Science2021
33888597Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident.Science2021
32533060Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.Nat Commun2020
32442065Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.J Clin Oncol2020
32533060Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.Nat Commun2020
32442065Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.J Clin Oncol2020
31171663RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.Science2019
31697821Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.Blood2019
31816062Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.Blood Adv2019
31142838Growth dynamics in naturally progressing chronic lymphocytic leukaemia.Nature2019
30922215A (fire)cloud-based DNA methylation data preprocessing and quality control platform.BMC Bioinformatics2019
31171663RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.Science2019
31164371Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.Clin Cancer Res2019
31816062Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.Blood Adv2019
31697821Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.Blood2019
30922215A (fire)cloud-based DNA methylation data preprocessing and quality control platform.BMC Bioinformatics2019
31142838Growth dynamics in naturally progressing chronic lymphocytic leukaemia.Nature2019
31164371Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma.Clin Cancer Res2019
29535149SvABA: genome-wide detection of structural variants and indels by local assembly.Genome Res2018
30262473Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".Science2018
30107175Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.Cancer Cell2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29941871DeTiN: overcoming tumor-in-normal contamination.Nat Methods2018
  • 1 - 50 of 140

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 13
Richard de Borja
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 13
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 2
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 40
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 5
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Career Start Year 2007
Number of shared co-authors 39
Moritz Gerstung
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 9
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year 2006
Number of shared co-authors 27
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 32
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 23
Ryan D Morin
Simon Fraser University
Career Start Year 2005
Number of shared co-authors 28
David Jones
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 25
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 10
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 37
Keiran Raine
Wellcome Sanger Institute
Career Start Year 2004
Number of shared co-authors 25
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 23
Michael Rusch
St Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 21
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 4
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 19
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 23
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 43
Jon Teague
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 31
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 22
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Career Start Year 1999
Number of shared co-authors 18
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 18
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 25
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 41
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 18
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 51

Collaborators

Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 57
Michael S Lawrence
Co-authored papers 23
Amaro Taylor-Weiner
Co-authored papers 22
Matthew Meyerson
Broad Institute
Co-authored papers 17
Mara Rosenberg
Broad Institute of MIT and Harvard
Co-authored papers 17
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 17
Scott L Carter
Co-authored papers 17
Jaegil Kim
Co-authored papers 17
Kristian Cibulskis
Co-authored papers 15
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 13
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 13
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 12
Donna Neuberg
Co-authored papers 12
Julian M Hess
Broad Institute of MIT and Harvard
Co-authored papers 11
Carrie Sougnez
The Broad Institute of Harvard and MIT
Co-authored papers 11
Catherine J Wu
Co-authored papers 10
Rameen Beroukhim
Co-authored papers 10
Aaron McKenna
Co-authored papers 10
Daniel Rosebrock
Co-authored papers 9
Aaron R Thorner
Co-authored papers 9
Dimitri Livitz
Co-authored papers 9
Petar Stojanov
Co-authored papers 7
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 7
Daniel Auclair
Co-authored papers 7
Esther Rheinbay
Co-authored papers 7
Sara Seepo
Co-authored papers 7
Chandra Sekhar Pedamallu
Broad Institute
Co-authored papers 7
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 6
Andrey Sivachenko
Cystic Fibrosis Foundation
Co-authored papers 6
Release 1.2